Hemodynamic Response to Treatment of Iron Deficiency Anemia in Pulmonary Arterial Hypertension: Longitudinal Insights From an Implantable Hemodynamic Monitor

Pulmonary Circulation - United States
doi 10.1086/688670
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Ambulatory Hemodynamic Monitoring in Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2008English

Iron Deficiency in Pulmonary Arterial Hypertension: A Potential Therapeutic Target

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2011English

The Hemodynamic Response to Dexmedetomidine Loading Dose in Children With and Without Pulmonary Hypertension

Survey of Anesthesiology
2014English

Intravenous Iron Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension and Iron Deficiency

Pulmonary Circulation
PulmonaryRespiratory Medicine
2015English

Corrigendum to “ECG Markers of Hemodynamic Improvement in Patients With Pulmonary Hypertension”

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Plasma sFlt-1 Fluctuations in Response to Pulmonary Arterial Hypertension Treatment

Cardiovascular Pharmacology: Open Access
2017English

Severe Cases of Pulmonary Arterial Hypertension: Saving Patients Under Conditions of Hemodynamic Collapse Is Not Easy

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

Serial Hemodynamic Monitoring to Guide Treatment of Maternal Hypertension Leads to Reduction in Severe Hypertension

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2017English

Novel Mutations in BMPR2, ACVRL1 and KCNA5 Genes and Hemodynamic Parameters in Patients With Pulmonary Arterial Hypertension

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy